Update on immunologic therapy with anti-CTLA-4 antibodies in melanoma: identification of clinical and biological response patterns, immune-related adverse events, and their management.

Source:http://linkedlifedata.com/resource/pubmed/id/21074064

Download in:

View as

General Info

PMID
21074064